Uveitis treatment shows promise

November 3, 2010

Curcumin-based treatment Norflo, has been shown to alleviate the symptoms of anterior uveitis in a recent study published in Clinical Ophthalmology, indicating a potential role for the anti-inflammatory treatment curcumin in eye inflammatory and degenerative conditions.

Curcumin-based treatment Norflo, has been shown to alleviate the symptoms of anterior uveitis in a recent study published in Clinical Ophthalmology, indicating a potential role for the anti-inflammatory treatment curcumin in eye inflammatory and degenerative conditions.

The study conducted by Dr Pia Allegri et al., examined the efficacy of an adjunctive-to-traditional treatment with Norflo tablets (curcumin-phosphatidylcholine complex; Meriva) in recurrent anterior uveitis of different aetiologies.

Norflo, administered twice daily, was found to be well-tolerated, reducing the symptoms of anterior uveitis of different origins in more than 80% of the 106 patients treated. Thus the study indicated that the treatment can play an important role in the adjunctive therapy of recurrent anterior uveitis of various origins.

For further details please click here